Fut, nem toborozFázis nélkül
Global Fenestrated Anaconda Clinical STudy
A legfontosabb adatok
- Ki végzi
- Vascutek Ltd.
- Hol
- Ausztrália, Ausztria, Egyesült Királyság, Hollandia és Kanada11 helyszín, 5 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 160 fő, tervezett
- Kezdés
- 2017. szept. 11.
- Várható befejezés
- 2030. dec. 31.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Vascutek Fenestrated Anaconda™ Custom AAA Stent Graft System
- A regiszteradat frissítve
- 2024. december 24.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 18 feltétel megnézéseKevesebb
Ki vehet részt
- Patients must meet all of the criteria below in order to be eligible for inclusion in the study -
- Patient is aged 18 years or over on the date of consent
- Patient is willing and able to comply with all study procedures and study follow-up visits
- Patient is willing and able to give written informed consent to participate in study
- Patient has a juxtrarenal or suprarenal abdominal aortic aneurysm (AAA) with maximum sac diameter ≥ 5.5cm, or an AAA ≥ 4.5 cm which has increased by > 1.0 cm in the past year
- Patient is anatomically suitable for a bifurcated Fenestrated Anaconda™ device; NOTE: Both the treating Investigator and the Manufacturer must agree that the proposed patient's anatomy is suitable for treatment using the Fenestrated Anaconda™ device. Where the Investigator proposes that the patient anatomy is suitable and the Manufacturer subsequently disagrees, the patient will be recorded as a screen failure and deemed not eligible for the study
Ki nem vehet részt
- Patient has had a previously inserted endovascular stent in the abdominal aorta
- Patient has psychiatric or other condition that in the opinion of the Investigator may limit their ability to comply with study procedures
- Patient has a known allergy to any device component (polyester, nitinol, nickel)
- Patient has a coagulopathy or uncontrolled bleeding disorder
- Patient has a connective tissue disease (e.g. Marfan Syndrome)
- Patient has a serum creatinine (S-Cr) level > 2.0 mg/dL (177 µmol/L)
- Patient has a life expectancy < 2 years, as judged by the Investigator
- Any patient who meets any of the criteria below will be excluded from participation in the study -
- Patient is participating in another clinical study which in the opinion of the Investigator could influence the outcomes of this study
- Patient has a ruptured, leaking or mycotic aneurysm
- Patient has had CVA or MI within three months of enrolment or treatment
- Patient is pregnant (female of childbearing potential only)
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
5 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is a prospective non-interventional, multi-centre study of the Vascutek Fenestrated Anaconda™ system, and is essentially a post-market study. The Vascutek Fenestrated Anaconda™ system is a custom made device used for the treatment of Abdominal Aortic Aneurysm.
A vizsgált kezelések
- Vascutek Fenestrated Anaconda™ Custom AAA Stent Graft System
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Prospective, Global, Multicentre, Real World Outcome Study of Fenestrated Endovascular Aneurysm Repair Using the Fenestrated Anaconda™ Device
- A regiszteradat frissítve
- 2024. december 24.